Annual ROE
-266.24%
-75.21%-39.37%
31 December 2023
Summary:
Mersana Therapeutics annual return on equity is currently -266.24%, with the most recent change of -75.21% (-39.37%) on 31 December 2023. During the last 3 years, it has fallen by -208.77% (-363.27%). MRSN annual ROE is now -791.89% below its all-time high of 38.48%, reached on 31 December 2015.MRSN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly ROE
-294.80%
-51.49%-21.16%
30 September 2024
Summary:
Mersana Therapeutics quarterly return on equity is currently -294.80%, with the most recent change of -51.49% (-21.16%) on 30 September 2024. Over the past year, it has dropped by -41.25% (-16.27%). MRSN quarterly ROE is now -139.22% below its all-time high of 751.72%, reached on 30 September 2017.MRSN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRSN ROE Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -39.4% | -16.3% |
| 3 y3 years | -363.3% | -305.2% |
| 5 y5 years | -63.2% | -524.4% |
MRSN ROE High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -363.3% | at low | -305.2% | at low |
| 5 y | 5 years | -363.3% | at low | -762.8% | at low |
| alltime | all time | -791.9% | +50.6% | -139.2% | +12.4% |
Mersana Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -294.80%(+21.2%) |
| June 2024 | - | -243.31%(-2.1%) |
| Mar 2024 | - | -248.57%(-2.9%) |
| Dec 2023 | -266.24%(+39.4%) | -256.03%(+1.0%) |
| Sept 2023 | - | -253.55%(+10.8%) |
| June 2023 | - | -228.74%(+11.9%) |
| Mar 2023 | - | -204.47%(+15.9%) |
| Dec 2022 | -191.03%(+96.5%) | -176.47%(+8.8%) |
| Sept 2022 | - | -162.18%(+25.0%) |
| June 2022 | - | -129.74%(+15.3%) |
| Mar 2022 | - | -112.56%(+19.0%) |
| Dec 2021 | -97.22%(+69.2%) | -94.60%(+30.0%) |
| Sept 2021 | - | -72.75%(+31.6%) |
| June 2021 | - | -55.27%(+6.1%) |
| Mar 2021 | - | -52.07%(+6.0%) |
| Dec 2020 | -57.47% | -49.11%(-0.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | -49.55%(-12.4%) |
| June 2020 | - | -56.57%(-21.2%) |
| Mar 2020 | - | -71.77%(+110.0%) |
| Dec 2019 | -64.76%(-60.3%) | -34.17%(-27.6%) |
| Sept 2019 | - | -47.21%(-13.7%) |
| June 2019 | - | -54.70%(-3.2%) |
| Mar 2019 | - | -56.53%(-62.9%) |
| Dec 2018 | -163.11%(-69.7%) | -152.35%(+56.0%) |
| Sept 2018 | - | -97.63%(-22.6%) |
| June 2018 | - | -126.09%(-0.6%) |
| Mar 2018 | - | -126.86%(-62.3%) |
| Dec 2017 | -538.53%(-2286.5%) | -336.57%(-144.8%) |
| Sept 2017 | - | 751.72%(+1016.0%) |
| June 2017 | - | 67.36%(-49.7%) |
| Mar 2017 | - | 134.02%(+444.1%) |
| Dec 2016 | 24.63%(-36.0%) | 24.63% |
| Dec 2015 | 38.48% | - |
FAQ
- What is Mersana Therapeutics annual return on equity?
- What is the all time high annual ROE for Mersana Therapeutics?
- What is Mersana Therapeutics annual ROE year-on-year change?
- What is Mersana Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Mersana Therapeutics?
- What is Mersana Therapeutics quarterly ROE year-on-year change?
What is Mersana Therapeutics annual return on equity?
The current annual ROE of MRSN is -266.24%
What is the all time high annual ROE for Mersana Therapeutics?
Mersana Therapeutics all-time high annual return on equity is 38.48%
What is Mersana Therapeutics annual ROE year-on-year change?
Over the past year, MRSN annual return on equity has changed by -75.21% (-39.37%)
What is Mersana Therapeutics quarterly return on equity?
The current quarterly ROE of MRSN is -294.80%
What is the all time high quarterly ROE for Mersana Therapeutics?
Mersana Therapeutics all-time high quarterly return on equity is 751.72%
What is Mersana Therapeutics quarterly ROE year-on-year change?
Over the past year, MRSN quarterly return on equity has changed by -41.25% (-16.27%)